When will a patient who has received ibritumomab tiuxetan with yttrium-90 (IT-Y90) reach the hematologic nadir?
1. During days 5-10
2. 10-14 days after infusion
3. In 30 days
4. In 7-9 weeks
Question 2
To help minimize side effects in a cancer patient receiving interferon-alfa therapy, the nurse should:
1. start oxygen.
2. lower the ambient temperature.
3. provide antiemetics.
4. administer acetaminophen.